Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the company of paying kickbacks to doctors who agreed to prescribe its HIV drugs, the U.S. attorney's ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

Gilead Sciences agreed to pay $202 million to the ... prescribe Gilead's HIV drugs and drive up sales," Clayton said. The settlement comes a month after a federal judge in New Jersey ruled that ...

Now, Gilead Sciences has agreed to fork over $202 million ... according to the government. As part of the settlement, Gilead admitted to certain conduct, such as paying one speaker more than ...

A patent dispute between ViiV Healthcare and Gilead Sciences has been resolved, with Gilead agreeing to pay a $1.25 billion settlement as well as royalties on sales of one of its top HIV products.

Gilead Sciences agreed to pay $202 million to the ... prescribe Gilead's HIV drugs and drive up sales," Clayton said. The settlement, which calls for Gilead to pay the U.S. nearly $177 million ...

Shares of Gilead Sciences Inc. GILD shed 2.30% to $101.43 Tuesday, on what proved to be an all-around mixed trading session ...

Gilead Sciences announced positive data regarding ... Over the three-year period ending April 2025, Gilead's total shareholder return reached 78.08%, presenting a stark contrast to more recent ...

Gilead Sciences to Pay $202 Million in US Settlement Over HIV Drug Kickbacks By Jonathan Stempel NEW YORK (Reuters) -Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit ...

The U.S. Attorney's Office joined Bellman's lawsuit against Gilead. The settlement, which calls for Gilead to pay the U.S. nearly $177 million and the balance to various states, was approved ...